Research Use Only. Not for human consumption, medical use, diagnosis, or treatment. By purchasing, you agree to laboratory use guidelines.
Retatrutide (RETAKLIK) 40mg
RETAKLIK is a synthetic triple receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways, designed exclusively for in vitro and in vivo laboratory research applications for studying metabolic regulation and receptor signalling in controlled settings. Supplied as 10mg/0.6mL, 40mg total per vial. All products are for research purposes only. Not for human consumption, medical use, diagnosis, or treatment.
Triple Tested
HPLC & MS verified for consistent potency thresholds.
Priority Post
Discreet Next Day Delivery on all research orders.
Janoshik Analytical Verification
All batches are independently verified. You can cross-reference the batch number with the report library.
View Certificate of Analysis →